Gastrin is more than a diagnostic marker — it is a key to understanding digestion and disease. Research into gastrin is advancing gastroenterology, from uncovering disease mechanisms to developing new treatments. Understanding this research helps providers and patients appreciate its importance.
Studies of gastrin are revealing how acid secretion is regulated, how gastrinomas develop,...
Deep inside your adrenal glands sits a receptor that plays a starring role in how your body responds to stress. The adrenocorticotropic hormone receptor, also known as the ACTH receptor or melanocortin-2 receptor, is the molecular switch that triggers cortisol production. When it malfunctions, the consequences can range from adrenal insufficiency to Cushing's syndrome. As research into these...
Targeted therapies are changing the landscape for NF2. Unlike traditional treatments, these drugs target specific molecular pathways involved in tumor growth. For patients with NF2, they offer new hope. The market is responding with investment and innovation.
Bevacizumab, which targets VEGF, is the most established targeted therapy for NF2. It can reduce tumor size and improve hearing in some...
Not every patient fits a standard prescription. Some need custom formulations — a different dose, a different form, or an ingredient not available commercially. Non-sterile compounding pharmacies fill this gap, creating customized medications for patients with unique needs. From flavored liquids for children to hormone therapies and dermatological creams, compounded medications are...
Cardiology radiopharmaceuticals are radioactive tracers used to image the heart, revealing blood flow, function, and metabolism. They are essential in diagnosing coronary artery disease, assessing heart damage, and guiding treatment. As cardiovascular disease remains a leading cause of death worldwide, demand for these diagnostics is growing. The cardiology radiopharmaceuticals market is...
English
